HIV & Hepatitis in the Americas 2018

View Calendar
2018-04-19 - 2018-04-21 Tutto il giorno
Hilton Mexico City Reforma Av. Juárez 70 Colonia Centro Centro, 06010 Mexico City Mexico
Phone:+52-55-5130-5300
Address: Av. Juárez 70, Colonia Centro, Centro, 06000 Ciudad de México, CDMX, Messico

HIV & Hepatitis in the Americas 2018

On behalf of the Core and Scientific Committees, we would like to introduce you to the HIV & Hepatitis in the Americas Congress. We are delighted to bring you the sixth Congress which has a unique regional focus, and evolved in 2013 from the HIV Glasgow Congress. The 2018 congress will be held in Mexico City, Mexico over 19-21 April 2018.

Our key aim in establishing this Congress was to bring together practising physicians and other healthcare professionals who treat patients on a day-to-day basis with a view to improving clinical practice and the lives of patients.

We have invited investigators from all the Latin American region to the Congress, in order to share ideas and results, and to promote research dissemination and create networking opportunities.

The Congress Scientific Programme has been developed to provide state-of-the-art information on HIV and hepatitis, as well as the opportunity to discuss regional issues and challenges in the treatment of patients, focussing on public health, and clinical and basic science agendas.

We are delighted to be working in collaboration with the International AIDS Society (IAS) and the Pan American Health Organization (PAHO), as we as the International Antiviral Society-USA (IAS-USA) and the Latin American Workshop Group. The involvement and activities of these groups during the Congress are detailed within the Scientific Programme.

The Scientific Programme offers a selection of plenary sessions, round table discussions and interactive case study-based sessions.

Time for discussion within sessions, which has increasingly become of value to delegates as the Congress has evolved, has been allocated to ensure that the key issues in the region are aired and addressed.

The inclusion of the hepatitis agenda within this 3-day programme was considered an important development in 2015, and continues to be a part of the Scientific Programme.

Important features of the Congress are the Scientific Posters and the Exhibition Area, which provide excellent opportunities to meet with colleagues, and to informally discuss data and generally embrace the nature of this Congress.

With the intention of continuing to develop the enthusiasm and momentum already gained, we encourage you to take an active part in the Congress and make the most of discussions, networking and other opportunities that present themselves.

Check the event website for more details.

Condividi:

Related upcoming events

  • 28th ECCMID - European Congress of Clinical Microbiology and Infectious Diseases
    2018-04-21 09:00 - 2018-04-24 22:00 Europe/Rome

    28th ECCMID - European Congress of Clinical Microbiology and Infectious Diseases - Madrid, 21-24 aprile 2018

    Media Information

    We welcome and encourage accredited journalists to cover the 28th ECCMID in Madrid, Spain.

    A press kit will be available from 21 April 2018 at the press centre.

    To register please send your press pass (or other credentials) via e-mail to Chantal Britt, ESCMID Communications Manager, chantal.britt[at]escmid.org

    ECCMID 2018 Media Policy

    The organizers of the 28th ECCMID European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2018) from 21 – 24 April 2018 in Madrid, Spain, welcome the press and are happy to provide assistance to journalists attending the congress or those using the congress website as a resource in their coverage.

    Registration

    The congress is open to bona fide representatives of print, broadcast and electronic media. Registration is free to journalists who are in possession of a valid, recognized press card. Freelance journalists must present a commissioning letter on headed paper from a recognized news organisation or publication, together with examples of previous, by-lined articles. Business cards are not acceptable.

    Embargoes

    Please respect embargo times and dates on news stories. It is planned that the large majority of the congress abstracts will go online at eccmidlive.org 10 days before the congress opens and can be reported from that time onwards. Some abstracts will be embargoed to coincide with the times they are presented at the congress. Embargo times and dates will be clearly marked on all press releases (also those from third parties).

    When asking for outside comment on releases before the embargo has lifted, journalists are requested to ensure that those consulted understand and accept the embargo conditions. ESCMID reserves the right to ban from the congress any journalist who breaks the embargoes or contravenes this media policy in any other way.

    Third-party press events

    Companies wishing to organize a news conference or any other event for the media during the congress should send a request in writing to the ESCMID communications manager. The programme, invitations and press releases sent out by any third party must be submitted to and agreed by ESCMID before the congress. Third-party press material may be displayed outside the Press Centre.

    eccmid.org

    Archivio congressi poloinformativo HIV

  • SYNChronicity 2018 The National Conference on HIV, HCV, and LGBT Health
    2018-04-22 09:00 - 2018-04-24 22:00 Europe/Rome

    SYNChronicity 2018 The National Conference on HIV, HCV, and LGBT Health

    SYNChronicity 2018 convenes clinicians, service providers, government officials, community-based organization staff, fiscal managers, consumers, and youth, among others, to address HIV, HCV, and LGBT health through education, training, networking, and resource sharing. Together, participants “SYNC” across systems, data, programs, models, interventions, and policies to create targeted solutions within a dynamic health care environment.

    Don’t miss this opportunity to engage with over 1,000 colleagues nationwide at SYNC 2018, featuring over 30 sessions and more than 100 presenters from diverse disciplines.

    A message from HealthHIV:

    "SYNChronicity convenes clinicians, service providers, government officials, community-based organization staff, fiscal managers, consumers, and youth, among others, to address HIV, HCV, and LGBT health through education, training, networking, and resource sharing. Together, participants “SYNC” across systems, data, programs, models, interventions, and policies to create targeted solutions within a dynamic health care environment.

    Don't miss this opportunity to engage with over 1,000 colleagues nationwide at SYNC 2018, featuring over 30 sessions and more than 100 presenters from diverse disciplines."

    Event Details

    SYNChronicity 2018:

    April 22-24, 2018
    Renaissance Arlington Capital View Hotel
    Arlington, VA

    Visit HealthHIV's SYNChronicity website for more details or to register: http://healthhiv.org/synchronicity/

    Facebook page: faceboFacebook.com/SYNChronicity2018/

    This event announcement is posted on behalf of HealthHIV and is not a function of the Forum for Collaborative Research

    Fonte: hivforum.org/forum-news/upcoming-events/1472-synchronicity-2018-the-national-conference-on-hiv-hcv-and-lgbt-health

     

  • 2018-05-16 08:55 - 2018-05-18 08:55 Europe/Rome

    We are proud to announce the 14th edition of the International Workshop on Co-infection: HIV, Hepatitis and Liver Disease, to be held on 16 - 18 May 2018 in Seville, Spain.

    With the success of antiretroviral therapy, HIV infected patients are seeing improvement in longevity, only to be challenged with the dangers and complications of additional viral infections. Depending on the country – this is either a majority, or a significant minority of the HIV patients under care. Although HIV & Hepatitis co-infection is a small part of several major HIV conferences, the field lacks a dedicated meeting on this topic. Over the years more and more educational components were added given the growing needs of clinicians to keep up with the rapid developments.

    The HIV & Hepatitis  coinfection workshop has become the most prestigious co-infection meeting in the field and is the leading medical gathering for those involved in the clinical care of co-infected individuals. The program provides an excellent platform to exchange the medical information and new treatment results, and to discuss them with the experts active in the different disciplines (including Virology, Hepatology, Immunology, Infectious Disease and Primary Care).

    The 2018-edition will continue to focus on developments in basic science, emerging therapies and clinical management. It will emphasize translational research and best practices in the clinical management of Hepatitis and HIV co-infection, and for the first time, include talks and topics on liver disease.

    We look forward to seeing you in Seville!

    Sito del congresso: virology-education.com

  • 2018-05-22 09:00 - 2018-05-24 22:00 Europe/Rome

    10° Congresso Nazionale ICARICAR 2018 - 10° Congresso Nazionale ICAR  Roma, 22-24 maggio 2018

    Cari Colleghi, Siamo lieti di annunciarvi che ICAR celebra il 10° Congresso Nazionale a Roma dal 22 al 24 maggio 2018.
    In continuità con la tradizione, ICAR 2018 mantiene la caratterizzazione di Congresso abstract-driven.

    Basandosi sull’interazione tra epidemiologia, ricerca di base, virologia, ricerca clinica e sulle esigenze della comunità delle associazioni dei pazienti, riservando grande visibilità ai giovani ricercatori ed ai rappresentanti della Community.

    Sono riconfermate le Scholarship Giovani Ricercatori, Scholarship Community e ICAR-CROI Awards dedicato alle giovani eccellenze italiane selezionate al prossimo Congresso CROI da una giuria di scienziati americani.

    In tema di sanità pubblica, anche l’edizione ICAR 2018 intende affrontare i problemi connessi alla cura ed alla prevenzione delle infezioni virali, aprendosi anche alla società civile.

    In questo ambito, si rinnova l’appuntamento con il concorso RaccontART e l’offerta del Test rapido HIV e HCV per la popolazione.

    Nei 10 anni di storia, ICAR ha segnato una continua crescita per numero e qualità di contributi scientifici, acquisendo nel contempo una valenza internazionale che lo colloca tra i più accreditati convegni del settore.

    Contiamo di proseguire su questo percorso, in collaborazione con tutti Voi.

    Un cordiale arrivederci a Roma!

    Massimo Andreoni
    Andrea Antinori
    Carlo Federico Perno
  • 2018-05-28 09:00 - 2018-06-02 20:00 Europe/Rome

    ESPID 2018 36th Annual Meeting of the European Society for Paediatric Infectious Diseases

    ESPID 2018 36th Annual Meeting of the European Society for Paediatric Infectious Diseases

    ESPID 2018: join thousands of clinicians, researchers, residents, and students who come together each year for the Annual Meeting of the European Society for Paediatric Infectious Diseases. Building on the success of previous meetings, ESPID Innovation brings you a scientific programme with a range of sessions and learning opportunities, given by the top international experts in paediatric infectious diseases. Come discover the latest developments in our fast-changing world in Malmö 2018!

    Congress Chairs: ​Lise Heilmann Jensen and Olof Hertting

    For more information http://espidmeeting.org

  • 2018-05-30 09:00 - 2018-06-01 20:00 Europe/Rome

    16th European Meeting on HIV & Hepatitis 2018

    16th European Meeting on HIV & Hepatitis 2018

    We are proud to announce the 16th European Meeting on HIV & Hepatitis - Treatment Strategies & Antiviral Drug Resistance, to be held on 30 May - 1 June 2018 at the Roma Eventi - Fontana di Trevi Conference Centre in Rome, Italy.

    The 16th European Meeting & Hepatitis is the premier European platform for clinicians, allied healthcare providers, researchers and clinical virologists to discuss the latest developments in antiviral therapy for HIV, HCV and HBV and for translating them into new treatment strategies to further improve clinical care.

    Founded sixteen years ago as the European HIV resistance workshop, the meeting evolved to embrace all aspects of clinical care of people living with HIV in Europe. Particular emphasis is put on optimal treatment strategies, clinical virology, molecular epidemiology and public health aspects of HIV, HBV and HCV infections throughout Europe.

    In the last decade the meeting has been able to capture leading clinicians and researchers from the different regions of Europe. As such, this meeting is the only European platform where HIV treating physicians and clinical virologists get together on an annual basis to present their latest research results and discuss their clinical implications in detail. The workshop has put a special emphasis on training young clinicians and scientists through clinical case discussions and parallel courses in collaboration with the European Society for Antiviral Research (ESAR).

    We look forward to seeing you in Rome!

  • 2018-07-23 09:00 - 2018-07-27 22:00 Europe/Rome

    22nd International AIDS Conference

    International AIDS Society statement on the passing of Amsterdam Mayor Eberhard van der Laan22nd International AIDS Conference

    International AIDS Society statement on the passing of Amsterdam Mayor Eberhard van der Laan

    posted on

    The International AIDS Society mourns the passing of Amsterdam Mayor Eberhard van der Laan and honours his life of service and dedication to an open society and to the fight against AIDS.

    Amsterdam, the city that Mayor van der Laan led for seven years, occupies a critical role in the history of the global fight against AIDS. It was among the first cities in the world to support needle exchange, which helped address a growing epidemic among people who inject drugs.

    In keeping with the city’s commitment to an evidence-based response to the epidemic, Amsterdam has long been a national and global centre of HIV-related research, including an ongoing trial comparing daily and intermittent use of pre-exposure antiretroviral prophylaxis. In 2018, Amsterdam will host the 22nd International AIDS Conference (AIDS 2018).

    “To stop the urban HIV epidemic, inclusivity is essential,” Mayor van der Laan said. His leadership vividly reflected this commitment to an open, transparent and participatory fight against HIV. Civil society and community groups play pivotal roles in the city’s response to the epidemic. Mayor van der Laan is globally renowned for his visible and unflagging commitment to the rights of LGBT people and to the broader human rights agenda.

    Under Mayor van der Laan, Amsterdam embarked on a historic effort to end its HIV epidemic. As of 2015, 94% of all people living with HIV in Amsterdam knew their HIV status and 79% of all people living with HIV achieved viral suppression. The number of new HIV diagnoses in Amsterdam has fallen by half in only five years.

    “Mayor van der Laan’s passion to address the needs of those left behind in the fight against AIDS was pivotal to our decision to host AIDS 2018 in Amsterdam,” said International AIDS Society President Linda-Gail Bekker. “We will miss him greatly and honour his commitment when we all come together next July.”

    “With the passing of Mayor van der Laan, we lose a tireless people’s champion. His empathy and unprecedented ability to connect have been hugely important for the city’s HIV response,”

    said Peter Reiss, Local Co-chair of AIDS 2018. “We are certain that the example of his leadership and the principles he so courageously championed will live on – not only in Amsterdam, but also around the world.”

     

  • HIV Drug Therapy Glasgow 2018 Conference - 28 to 31 October 2018
    2018-10-28 - 2018-10-31 Tutto il giorno

    HIV Drug Therapy Glasgow 2018 Conference - 28 to 31 October 2018

    HIV Drug Therapy-

    The programme is of interest to clinical investigators from across the globe to review current research and discuss its implications for HIV management strategies.

    Although there has been steady progress in HIV drug treatment, significant challenges still remain, including persistence of elevated risk of non-AIDS morbidity, with potential for HIV and/or antiretroviral therapy (ART) as causes, paediatric and adolescent care, models of care for the ageing population, and treatment issues throughout less well-resourced parts of Europe and the rest of the world.

    The Congress is also moving into areas beyond treatment, such as prevention, with time in the programme focussed on pre-exposure prophylaxis (PrEP) and issues across Europe and beyond.

    The important role of people living with HIV in treatment decisions and self-management continues to feature, and we look forward to a number of perspectives in the programme from the community.

    The programme maintains the plenary session presentation format. In addition to plenary presentations, the programme will include Keynote Lectures, the Lock Lecture, Industry Sessions and presentations based on abstracts submitted.

    The congress welcomes abstract submissions, and whilst only a small number can be accepted for oral presentation, we anticipate a sizeable display of Scientific Posters in the Congress Exhibition Hall throughout the Congress.

    Vai al sito della conferenza

  • Le Malattie Infettive del migrante e del viaggiatore a Ferrara - Italy
    2018-11-09 Tutto il giorno

    Le Malattie Infettive del migrante e del viaggiatore a Ferrara - Italy

    Le Malattie Infettive del migrante e del viaggiatore a Ferrara - ItalyQuesto testo è stato redatto in occasione del congresso del 2016
    Malattie Infettive del migrante: In Italia, negli ultimi vent’anni, la popolazione immigrata è cresciuta di quasi 20 volte, subendo, nell’ultimo decennio, un incremento pari a oltre il 150%, con rilevanti differenze tra le regioni.

    Al quel patrimonio di salute in dotazione all’immigrato che appariva giovane, forte, con maggiore stabilità psicologica e spirito d’iniziativa e quindi più sano (effetto migrante sano), si è contrapposto, al suo arrivo in Italia o in altri paesi ospitanti, un patrimonio che si sta dissolvendo sempre più rapidamente (effetto migrante esausto), per malessere psicologico, mancanza di lavoro e reddito, degrado abitativo, assenza di supporto familiare.

    La nuova organizzazione della vita conseguente al totale sradicamento dall’ambiente di origine e dalle proprie sicurezze è divenuta e diviene così ogni giorno fonte di stress e pericoli per la salute.

    In tale contesto, anche le Malattie Infettive del migrante, pur non preponderanti tra le patologie del migrante, rappresentano un importante focus del fenomeno migratorio, anche se spesso identificano il migrante quale untore da bonificare e da cui difenderci.

    È innegabile che l’emergere di nuove patologie infettive e la ricomparsa di altre che sembravano destinate a ridursi o addirittura destinate ad estinguersi, rappresentano argomenti più che mai attuali nella società in cui viviamo e perciò riportate all’attenzione in questa nuova edizione del Convegno.

    Il rischio di contrarre la TB è pari a 10-15 volte in più tra gli immigrati rispetto alla popolazione italiana, per la fragilità sociale legata al processo migratorio e al paese ospitante, in cui l’incidenza è assai bassa e stabile (5-7 casi/100.000 abitanti). L’infezione da HIV/AIDS, evidenzia un costante e rapido aumento nel tempo dei casi notificati in stranieri, con un tasso di incidenza di quasi 4 volte superiore a quella italiana.

    A questa si aggiungono le altre Malattie Sessualmente trasmesse facilitate anche dalle condizioni di sfruttamento sessuale cui sono sottoposti donne e uomini immigrati.

    La tutela della salute dei migranti è oramai divenuta una delle sfide in Sanità Pubblica e riguarda proprio la necessità di garantire percorsi di tutela a coloro che per vari motivi si trovano a vivere ancora ai margini del sistema, in condizioni di fragilità sociale, economica e culturale.

    Le caratteristiche interdisciplinari del convegno permetteranno ai partecipanti di interagire con tutte le professionalità presenti, stimolando la collaborazione e migliorando il network di assistenza all'utente. Giunto alla sua quinta edizione, il convegno, organizzato dal Prof. Carlo Contini, oltre a fare il punto sulla situazione socio-sanitaria dei migranti nel nostro Paese, focalizza anche gli aspetti epidemiologici e clinici delle nuove Malattie Infettive del migrante, emergenti e riemergenti anche legate ai viaggi che hanno un impatto considerevole sulla salute pubblica.

    Fonte: simit